These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20412103)

  • 21. Calprotectin: a novel noninvasive marker for intestinal allograft monitoring.
    Sudan D; Vargas L; Sun Y; Bok L; Dijkstra G; Langnas A
    Ann Surg; 2007 Aug; 246(2):311-5. PubMed ID: 17667511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Measurement of calprotectin in faeces].
    Jahnsen J; Røseth AG; Aadland E
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):743-5. PubMed ID: 19373299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markers of intestinal inflammation for the diagnosis of infectious gastroenteritis.
    Gonzalez MD; Wilen CB; Burnham CA
    Clin Lab Med; 2015 Jun; 35(2):333-44. PubMed ID: 26004646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective multicenter study evaluating fecal calprotectin in adult acute bacterial diarrhea.
    Shastri YM; Bergis D; Povse N; Schäfer V; Shastri S; Weindel M; Ackermann H; Stein J
    Am J Med; 2008 Dec; 121(12):1099-106. PubMed ID: 19028207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute gastroenteritis in children.
    Webb A; Starr M
    Aust Fam Physician; 2005 Apr; 34(4):227-31. PubMed ID: 15861741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Faecal calprotectin: a new marker for Crohn's disease?
    Wassell J; Dolwani S; Metzner M; Losty H; Hawthorne A
    Ann Clin Biochem; 2004 May; 41(Pt 3):230-2. PubMed ID: 15117438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I
    Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis of acute diarrheal infections].
    Ivanov KS; Ivanov AI
    Klin Med (Mosk); 1992; 70(7-8):64-9. PubMed ID: 1460834
    [No Abstract]   [Full Text] [Related]  

  • 30. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
    Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Forbes A; Bjarnason I; Sherwood RA; Ciclitira P; Nicholls JR
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers.
    Joshi S; Lewis SJ; Creanor S; Ayling RM
    Ann Clin Biochem; 2010 May; 47(Pt 3):259-63. PubMed ID: 19740914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil CD64 expression as a diagnostic marker of bacterial infection in febrile children presenting to a hospital emergency department.
    Rudensky B; Sirota G; Erlichman M; Yinnon AM; Schlesinger Y
    Pediatr Emerg Care; 2008 Nov; 24(11):745-8. PubMed ID: 18955911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic aspirin therapy does not increase faecal calprotectin concentrations.
    Montalto M; Curigliano V; Santoro L; Lombardi M; Covino M; Cammarota G; Dalvai S; D'Onofrio F; Gasbarrini A; Gasbarrini G
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):965-7. PubMed ID: 16894309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of iron supplementation on dominant bacterial groups in the gut, faecal SCFA and gut inflammation: a randomised, placebo-controlled intervention trial in South African children.
    Dostal A; Baumgartner J; Riesen N; Chassard C; Smuts CM; Zimmermann MB; Lacroix C
    Br J Nutr; 2014 Aug; 112(4):547-56. PubMed ID: 24916165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial and viral causes of acute diarrhoea in children in Kuwait.
    Sethi SK; Khuffash F
    J Diarrhoeal Dis Res; 1989; 7(3-4):85-8. PubMed ID: 2632640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute gastroenteritis caused by multiple enteric pathogens in children.
    Chen SY; Tsai CN; Chao HC; Lai MW; Lin TY; Ko TY; Chiu CH
    Epidemiol Infect; 2009 Jul; 137(7):932-5. PubMed ID: 19046476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectal NO and fecal calprotectin in IBD.
    Lundberg JO
    Scand J Gastroenterol; 2009; 44(1):128. PubMed ID: 19101857
    [No Abstract]   [Full Text] [Related]  

  • 39. [Children hospitalized with acute gastroenteritis. II. No relation between clinical symptoms and causative agents isolated from feces].
    Tjon A Ten WE
    Ned Tijdschr Geneeskd; 1999 Feb; 143(6):306-8. PubMed ID: 10221087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response.
    Turner D; Leach ST; Mack D; Uusoue K; McLernon R; Hyams J; Leleiko N; Walters TD; Crandall W; Markowitz J; Otley AR; Griffiths AM; Day AS
    Gut; 2010 Sep; 59(9):1207-12. PubMed ID: 20801771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.